CliffBio
small molecule

METOPROLOL TARTRATE

METOPROLOL TARTRATE

Loss of exclusivity—loss of exclusivity
CompanyAlembic →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETOPROLOL TARTRATE
Active ingredientMETOPROLOL TARTRATE
Strength50MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2013
Marketing statusRX

More from Alembic

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.